Tomoo Nakagawa Selected Research

Tomoo Nakagawa Research Topics

Disease

8	Hemorrhage 01/2019 - 05/2011
7	Crohn Disease (Crohn's Disease) 10/2019 - 04/2014
6	Stomach Neoplasms (Stomach Cancer) 09/2020 - 04/2014
5	Gastroesophageal Reflux (GERD) 01/2020 - 06/2013
5	Ulcerative Colitis 10/2019 - 07/2010
5	Ulcer 08/2019 - 04/2014
4	Neoplasms (Cancer) 09/2020 - 05/2004
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2013
2	Diabetes Mellitus 01/2021 - 01/2018
2	Chronic Renal Insufficiency 01/2021 - 10/2014
2	Esophagitis 01/2020 - 06/2017
2	Disease Progression 08/2019 - 12/2018
2	Lymphoma (Lymphomas) 08/2019 - 12/2016
2	Pathologic Constriction (Stenosis) 01/2018 - 12/2016
2	Adenoma (Adenomas) 01/2018 - 06/2015
2	Polyps 08/2017 - 01/2017
2	Colitis 01/2015 - 02/2010
1	Dyspepsia (Indigestion) 10/2021
1	Ischemic Stroke 01/2021
1	Myocardial Infarction 01/2021
1	Transient Ischemic Attack 01/2021
1	Atherosclerosis 01/2021
1	Infections 02/2020
1	Necrosis 09/2019
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2019
1	Ileus 08/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Alopecia (Baldness) 09/2018
1	Leukopenia 09/2018
1	Eosinophilic Esophagitis 01/2018
1	Anorexia 01/2018
1	Fever (Fevers) 01/2018
1	Vomiting 01/2018
1	Hepatitis B 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Nausea 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Incisional Hernia 10/2017
1	Heartburn (Pyrosis) 06/2017
1	Peritonitis 12/2016

Drug/Important Bio-Agent (IBA)

7	Proton Pump InhibitorsIBA 02/2020 - 06/2013
5	Capsules (Microcapsules)IBA 01/2019 - 05/2011
3	Adalimumab (Humira)FDA Link 09/2019 - 11/2016
3	Azathioprine (Imuran)FDA LinkGeneric 09/2019 - 11/2016
2	AcidsIBA 10/2021 - 06/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	2-mercaptopurineIBA 09/2019 - 09/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 05/2011
2	Heparin (Liquaemin)FDA LinkGeneric 01/2017 - 10/2014
2	Esomeprazole (Nexium)FDA Link 01/2017 - 11/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2014 - 05/2011
2	Messenger RNA (mRNA)IBA 04/2014 - 04/2014
2	Bombesin Receptors (Bombesin Receptor)IBA 01/2006 - 05/2004
2	BombesinIBA 01/2006 - 05/2004
2	CamptothecinIBA 09/2005 - 05/2004
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2005 - 05/2004
1	AntibodiesIBA 01/2021
1	AntigensIBA 01/2021
1	Recombinant ProteinsIBA 01/2021
1	Complementary DNA (cDNA)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	B7-H1 AntigenIBA 09/2020
1	InterferonsIBA 09/2020
1	Pepsin A (Pepsin)IBA 01/2020
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2020
1	CT-P13IBA 10/2019
1	Infliximab (Remicade)FDA Link 10/2019
1	Biosimilar PharmaceuticalsIBA 10/2019
1	DiamondIBA 09/2019
1	Monoclonal AntibodiesIBA 09/2019
1	Immunomodulating AgentsIBA 08/2019
1	Immunologic Factors (Immunomodulators)IBA 08/2019
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	EnzymesIBA 09/2018
1	Codon (Codons)IBA 09/2018
1	cysteinylcysteineIBA 09/2018
1	arginylarginine (Arg-Arg)IBA 09/2018
1	Tight Junction ProteinsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	Granisetron (Kytril)FDA LinkGeneric 01/2018
1	beta-Aminoethyl Isothiourea (AET)IBA 06/2017
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2017
1	CellophaneIBA 12/2016
1	Apoptosis Regulatory ProteinsIBA 06/2015
1	bcl-X ProteinIBA 06/2015
1	Phenobarbital (Luminal)FDA Link 06/2015
1	maleic acid (maleate)IBA 01/2015
1	Pharmaceutical PreparationsIBA 01/2015

Therapy/Procedure

8	Therapeutics 10/2019 - 06/2013
2	Renal Dialysis (Hemodialysis) 01/2019 - 10/2014
1	Drug Therapy (Chemotherapy) 08/2019
1	Conservative Treatment 08/2019
1	Catheters 01/2018
1	Endoscopic Hemostasis 10/2017
1	Surgical Instruments (Clip) 08/2017
1	Blood Component Removal (Apheresis) 11/2015